Increased plasma amyloid β protein 1-42 levels in Down syndrome
- Autor
- MEHTA, P. D1 ; DALTON, A. J2 ; MEHTA, S. P1 ; KWANG SOO KIM3 ; SERSEN, E. A4 ; WISNIEWSKI, H. M5
[1] Department of Immunology, New York State Institute for Basic Research, 1050 Forest Hill Road, Staten Island, New York 10314-6399, United States
[2] Laboratory of Aging Processes, New York State Institute for Basic Research, 1050 Forest Hill Road, Staten Island, New York 10314-6399, United States
[3] Department of Virology, New York State Institute for Basic Research, 1050 Forest Hill Road, Staten Island, New York 10314-6399, United States
[4] Department of Biostatistics, New York State Institute for Basic Research, 1050 Forest Hill Road, Staten Island, New York 10314-6399, United States
[5] Department of Pathological Neurobiology, New York State Institute for Basic Research, 1050 Forest Hill Road, Staten Island, New York 10314-6399, United States - Fuente
Neuroscience letters. 1998, Vol 241, Num 1, pp 13-16 ; ref : 18 ref
- CODEN
- NELED5
- ISSN
- 0304-3940
- Campo Científico
- Neurology; Physiology, morphology
- Editor
- Elsevier, Shannon
- País de la publicación
- Ireland
- Tipo de documento
- Article
- Idioma
- English
- Palabra clave (fr)
- Arriération mentale Homme Mongolisme Plasma sanguin Protéine amyloïde β Technique ELISA Aberration chromosomique Aneuploïdie Trisomie
- Palabra clave (in)
- Mental retardation Human Down syndrome Blood plasma β Amyloid protein ELISA assay Chromosomal aberration Aneuploidy Trisomy
- Palabra clave (es)
- Retraso mental Hombre Mongolismo Plasma sanguíneo Proteína amiloide β Técnica ELISA Aberración cromosómica Aneuploidía Trisomía
- Clasificación
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B23 Medical genetics / 002B23B Chromosome aberrations
- Disciplina
- Medical genetics
- Procedencia
- Inist-CNRS
- Base de datos
- PASCAL
- Identificador INIST
- 2151951
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Acceso al documento
Install on your browser
DOI
10.1016/S0304-3940(97)00966-X 
https://dx.doi.org/10.1016/S0304-3940(97)00966-X
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0304-3940(97)00966-X\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:64:\"Increased plasma amyloid \u03b2 protein 1-42 levels in Down syndrome\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Neuroscience letters\";s:9:\"\u0000*\u0000stitle\";s:14:\"Neurosci. lett\";s:7:\"\u0000*\u0000date\";s:4:\"1998\";s:9:\"\u0000*\u0000volume\";s:3:\"241\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"13\";s:8:\"\u0000*\u0000epage\";s:2:\"16\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0304-3940\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MEHTA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"P. D\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:12:\"DALTON, A. J\";i:1;s:11:\"MEHTA, S. P\";i:2;s:13:\"KWANG SOO KIM\";i:3;s:12:\"SERSEN, E. A\";i:4;s:16:\"WISNIEWSKI, H. M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NELED5\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:64:\"Increased plasma amyloid \u03b2 protein 1-42 levels in Down syndrome\";s:8:\"\u0000*\u0000place\";s:7:\"Shannon\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Acceso mediante Panist
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0304-3940(97)00966-X\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:64:\"Increased plasma amyloid \u03b2 protein 1-42 levels in Down syndrome\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Neuroscience letters\";s:9:\"\u0000*\u0000stitle\";s:14:\"Neurosci. lett\";s:7:\"\u0000*\u0000date\";s:4:\"1998\";s:9:\"\u0000*\u0000volume\";s:3:\"241\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"13\";s:8:\"\u0000*\u0000epage\";s:2:\"16\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0304-3940\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MEHTA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"P. D\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:12:\"DALTON, A. J\";i:1;s:11:\"MEHTA, S. P\";i:2;s:13:\"KWANG SOO KIM\";i:3;s:12:\"SERSEN, E. A\";i:4;s:16:\"WISNIEWSKI, H. M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NELED5\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:64:\"Increased plasma amyloid \u03b2 protein 1-42 levels in Down syndrome\";s:8:\"\u0000*\u0000place\";s:7:\"Shannon\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Acceso mediante Istex
"O:16:\"UnpaywallOpenUrl\":35:{s:8:\"\u0000*\u0000email\";s:27:\"assistance-portail@inist.fr\";s:6:\"\u0000*\u0000fmt\";N;s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0304-3940(97)00966-X\";s:6:\"\u0000*\u0000pii\";N;s:7:\"\u0000*\u0000pmid\";N;s:9:\"\u0000*\u0000atitle\";N;s:9:\"\u0000*\u0000jtitle\";N;s:9:\"\u0000*\u0000stitle\";N;s:7:\"\u0000*\u0000date\";N;s:9:\"\u0000*\u0000volume\";N;s:8:\"\u0000*\u0000issue\";N;s:8:\"\u0000*\u0000spage\";N;s:8:\"\u0000*\u0000epage\";N;s:8:\"\u0000*\u0000pages\";N;s:7:\"\u0000*\u0000issn\";N;s:8:\"\u0000*\u0000eissn\";N;s:9:\"\u0000*\u0000aulast\";N;s:10:\"\u0000*\u0000aufirst\";N;s:9:\"\u0000*\u0000auinit\";N;s:10:\"\u0000*\u0000auinitm\";N;s:5:\"\u0000*\u0000au\";N;s:9:\"\u0000*\u0000aucorp\";N;s:7:\"\u0000*\u0000isbn\";N;s:8:\"\u0000*\u0000coden\";N;s:8:\"\u0000*\u0000genre\";N;s:7:\"\u0000*\u0000part\";N;s:9:\"\u0000*\u0000btitle\";N;s:8:\"\u0000*\u0000title\";N;s:8:\"\u0000*\u0000place\";N;s:6:\"\u0000*\u0000pub\";N;s:10:\"\u0000*\u0000edition\";N;s:9:\"\u0000*\u0000tpages\";N;s:9:\"\u0000*\u0000series\";N;s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";N;}"
Acceso mediante Unpaywall
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0304-3940(97)00966-X\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:64:\"Increased plasma amyloid \u03b2 protein 1-42 levels in Down syndrome\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Neuroscience letters\";s:9:\"\u0000*\u0000stitle\";s:14:\"Neurosci. lett\";s:7:\"\u0000*\u0000date\";s:4:\"1998\";s:9:\"\u0000*\u0000volume\";s:3:\"241\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"13\";s:8:\"\u0000*\u0000epage\";s:2:\"16\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0304-3940\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MEHTA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"P. D\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:12:\"DALTON, A. J\";i:1;s:11:\"MEHTA, S. P\";i:2;s:13:\"KWANG SOO KIM\";i:3;s:12:\"SERSEN, E. A\";i:4;s:16:\"WISNIEWSKI, H. M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NELED5\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:64:\"Increased plasma amyloid \u03b2 protein 1-42 levels in Down syndrome\";s:8:\"\u0000*\u0000place\";s:7:\"Shannon\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Acceso mediante Europe PubMed Central
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:29:\"10.1016\/S0304-3940(97)00966-X\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:64:\"Increased plasma amyloid \u03b2 protein 1-42 levels in Down syndrome\";s:9:\"\u0000*\u0000jtitle\";s:20:\"Neuroscience letters\";s:9:\"\u0000*\u0000stitle\";s:14:\"Neurosci. lett\";s:7:\"\u0000*\u0000date\";s:4:\"1998\";s:9:\"\u0000*\u0000volume\";s:3:\"241\";s:8:\"\u0000*\u0000issue\";s:1:\"1\";s:8:\"\u0000*\u0000spage\";s:2:\"13\";s:8:\"\u0000*\u0000epage\";s:2:\"16\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0304-3940\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:5:\"MEHTA\";s:10:\"\u0000*\u0000aufirst\";s:4:\"P. D\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:5:{i:0;s:12:\"DALTON, A. J\";i:1;s:11:\"MEHTA, S. P\";i:2;s:13:\"KWANG SOO KIM\";i:3;s:12:\"SERSEN, E. A\";i:4;s:16:\"WISNIEWSKI, H. M\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"NELED5\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:64:\"Increased plasma amyloid \u03b2 protein 1-42 levels in Down syndrome\";s:8:\"\u0000*\u0000place\";s:7:\"Shannon\";s:6:\"\u0000*\u0000pub\";s:8:\"Elsevier\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Acceso mediante arXiv
